6-(tert-Butoxycarbonyl)-5,6,7,8-tetrahydropyrido[3,4-b]pyrazine-7-carboxylic acid, 95.0%, 250mg

N-Methylpyrazolo[1,5-a]pyridine-2-carboxamide, 98%, 5g

methyl 1-(2-methoxyethyl)-1H-pyrazole-5-carboxylate, 95.0%, 500mg

(4S,4'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-isopropyl-4,5-dihydrooxazole), 97%, 250mg

Symbole d'avertissement selon ISO 7010 sur la feuille, Surface chaude, Longueur de côté 50 mm, 1 pièce

4-Chloro-8-nitroquinoline, 95.0%, 10g

4-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine, 97.0%, 250mg

N-methyl-3-morpholin-4-ylpropan-1-amine dihydrochloride, 95.0%, 250mg

2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde, 98.0%, 10g

Cis-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-3-carboxylic acid, 95.0%, 250mg

Triphenylphosphine dibromide, 95.0%, 1g

4-Fluoro-1-naphthaldehyde, 95.0%, 10g

Fluvoxamine Maleate>98.0%(HPLC)(T)1g